A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression
This is a study evaluating the efficacy, and safety of KH607 in 72 participants diagnosed with Postpartum Depressive Disorder.
Age: 18 to 45 years old (inclusive), female. [+5]
Participant is currently at significant risk of suicide, or has attempted suicid... [+6]